ArticleOncotarget2015

Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases.

Valerio Leoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.